The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
G-CSF utilization during abiraterone acetate (AA) and cabazitaxel (C) therapy: A retrospective U.S. claims analysis.
Maneesha Mehra
Employment or Leadership Position - Janssen Pharmaceutical
Robert Stellhorn
Employment or Leadership Position - Janssen Pharmaceutical
Stock Ownership - Johnson & Johnson
Yvette Ng
Employment or Leadership Position - Janssen Pharmaceutical ; Janssen Research & Development
Stock Ownership - Johnson & Johnson
Mary Beth Todd
Employment or Leadership Position - Janssen Pharmaceutical